Scaling or wider bioequivalence limits for highly variable drugs and for the special case of Cmax
- 1 May 2003
- journal article
- research article
- Published by Dustri-Verlgag Dr. Karl Feistle in International journal of clinical pharmacology and therapeutics
- Vol. 41 (5), 217-225
- https://doi.org/10.5414/cpp41217